6xa9
From Proteopedia
(Difference between revisions)
m (Protected "6xa9" [edit=sysop:move=sysop]) |
|||
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==SARS CoV-2 PLpro in complex with ISG15 C-terminal domain propargylamide== | |
| + | <StructureSection load='6xa9' size='340' side='right'caption='[[6xa9]], [[Resolution|resolution]] 2.90Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6XA9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6XA9 FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.9Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AYE:PROP-2-EN-1-AMINE'>AYE</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6xa9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6xa9 OCA], [https://pdbe.org/6xa9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6xa9 RCSB], [https://www.ebi.ac.uk/pdbsum/6xa9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6xa9 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| - | + | ==See Also== | |
| - | + | *[[Virus protease 3D structures|Virus protease 3D structures]] | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| + | [[Category: Large Structures]] | ||
| + | [[Category: Calleja DJ]] | ||
| + | [[Category: Klemm T]] | ||
| + | [[Category: Komander D]] | ||
| + | [[Category: Lechtenberg BC]] | ||
| + | [[Category: Richardson LW]] | ||
Current revision
SARS CoV-2 PLpro in complex with ISG15 C-terminal domain propargylamide
| |||||||||||
